Delayed graft function in pediatric living donor kidney transplantation

Christine S Hwang1,2, Yash Kadakia3, Jorge A Sanchez-Vivaldi1,2

  • 1Division of Surgical Transplantation, Department of Surgery, University Of Texas Southwestern Medical Center, Dallas, Texas, USA.

Pediatric Transplantation
|November 12, 2022
PubMed

Insights

Delayed graft function (DGF) in pediatric living donor kidney transplants significantly impacts outcomes. Patients experiencing DGF had substantially lower 1-year allograft survival rates, highlighting the need for optimized donor-recipient matching.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Pediatric Surgery

Background:

  • Pediatric living donor kidney transplantation is associated with a low incidence of delayed graft function (DGF).
  • Understanding the specific risk factors and consequences of DGF in this population is crucial for improving patient outcomes.
  • This study investigates DGF in pediatric recipients of living donor kidney allografts.

Purpose of the Study:

  • To determine the incidence and identify risk factors for delayed graft function (DGF) in pediatric living donor kidney transplant recipients.
  • To evaluate the impact of DGF on post-transplant outcomes, including graft survival and rejection rates.
  • To provide insights for optimizing donor-recipient matching to mitigate DGF risks.

Main Methods:

  • A retrospective analysis of the STARfile database was conducted for pediatric patients receiving living donor kidney transplants between 2000 and 2020.
  • Recipient and donor demographic data, along with transplant outcomes, were analyzed.
  • Delayed graft function (DGF) was defined as the requirement for dialysis within the first week post-transplantation.

Main Results:

  • Out of 6480 pediatric living donor kidney transplants, 269 (4.2%) experienced DGF.
  • Smaller recipient weight (<15 kg) was significantly associated with a higher incidence of DGF.
  • Recipients with DGF had doubled length of stay, increased rejection rates, and markedly worse 1-year allograft survival (67% vs. 98%).

Conclusions:

  • Delayed graft function (DGF) in pediatric living donor kidney transplant recipients is linked to significantly poorer allograft survival.
  • Identifying and mitigating risk factors, such as small recipient size, is essential.
  • Optimizing donor-recipient matching strategies may improve long-term outcomes for these patients.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
36
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
53
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
61